Loading…
About Dr. Roland Meier
Pharmaceutical, medical, and clinical consulting leadership grounded in decades of scientific rigor and industry experience.
Dr. Roland Meier, M.D., Ph.D.
Founder & Principal Consultant
Dr. Roland Meier received his M.D. from the University of Zurich, Switzerland, and his Ph.D. from the Université de Lausanne, Switzerland, where he also completed his training as a pediatrician and pediatric oncologist. Before transitioning to the pharmaceutical industry, he held a postdoctoral fellowship at a leading research institution in Berkeley, California.
Throughout his distinguished career, Dr. Meier has led the launch of several new drugs and indications, creating meaningful opportunities for patients to receive life-extending therapies faster through the design and implementation of early access programs.
Following his postdoctoral training, Dr. Meier entered the pharmaceutical industry in Medical Affairs, later advancing into clinical development after completing specialized training in pharmacovigilance. He has led multiple antibody-drug conjugate (ADC) programs and played a pioneering role in immuno-oncology during its earliest stages. His therapeutic experience spans immunology, radiotherapies, and complex drug combinations across a wide range of indications.
Dr. Meier combines a hands-on, execution-oriented working style with leadership experience at both major pharmaceutical companies and startup biotechs — including serving as Chief Medical Officer (CMO).
He is the founder and owner of Princeton MedSolutions LLC, where he serves as an independent clinical consultant, medical monitor, safety physician, clinical advisor, and fractional CMO for biotech and pharmaceutical organizations.
Career Highlights
A career built on scientific excellence, clinical leadership, and pharmaceutical innovation.
M.D., University of Zurich
Ph.D., Université de Lausanne
Pediatrician & Pediatric Oncologist Training
Postdoctoral Fellowship, Berkeley, CA
Medical Affairs Leadership
Clinical Development Leadership
ADC Program Leadership
Early Immuno-Oncology Experience
Pharmacovigilance Training
CMO at Startup Biotechs
Founder, Princeton MedSolutions
Areas of Expertise
Deep domain knowledge spanning the full pharmaceutical development lifecycle.
Clinical Development
Leading clinical programs from early-phase through registration across multiple therapeutic areas, with a focus on oncology and immunology.
Immuno-Oncology
Pioneering involvement in immuno-oncology during its early days, with experience across IO drugs, immunology, radiotherapies, and drug combinations.
Medical Affairs
Strategic medical affairs leadership including scientific communication, stakeholder engagement, and cross-functional medical guidance.
Pharmacovigilance
Formal training and hands-on experience in pharmacovigilance, safety review, risk management, and clinical safety oversight.
Biotech & Pharma Leadership
Executive-level experience at both major pharmaceutical companies and emerging biotechs, including serving as Chief Medical Officer.
Independent Consulting
Serving as an independent clinical consultant, medical monitor, safety physician, and fractional CMO for organizations across the industry.
Work with Dr. Meier
Looking for experienced pharmaceutical and clinical consulting leadership? Let's discuss how Princeton MedSolutions can support your organization.